Generic Name:
Blinatumomab
Storage Condition:
2°C TO 8°C Temperature
Packing:
1 Vial
Mfg / Mkd By:
Amgen
Doses:
Therapeutic Use:
Description:
Mechanism Of Action of Blincyto 35mcg (Blinatumomab) Injection:It targets malignant and benign B cells via the CD19 cell surface antigen, while simultaneously engaging the patient's own T cells through the CD3.
Administration of Blincyto 35mcg (Blinatumomab) Injection:It is to be used as Intravenous Infusion.Do not self-medicate the therapy.Use it under a medical supervision only.
Therapeutic Use of Blincyto 35mcg (Blinatumomab) Injection:It is used to treat a blood cancer called B-precursor acute lymphoblastic leukaemia (ALL) in adults and children.
Our Other Products
View All
Carboplatin
Generic Name: Carboplatin
6-MP (Mercaptopurine) 50 mg
Generic Name: Mercaptopurine
Abevmy (Bevacizumab) 100 mg/4ml
Generic Name: Bevacizumab
Abione (Abiraterone Acetate) 250 mg
Generic Name: Abiraterone Acetate